Evaluation of a Decentralized Donor-Derived Cell-Free DNA Assay for Kidney Allograft Rejection Monitoring
Transplant International · 2024
DOI: 10.3389/ti.2024.13919 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Transplant International, 2024. Verfasst von Alexandre Loupy und 15 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, Institut national de la santé et de la recherche médicale (INSERM) U970, Paris Institute for Transplantation and Organ Regener…. Hauptthemen laut MEDLINE: Kidney Transplantation, Graft Rejection, Cell-Free Nucleic Acids, Tissue Donors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Donor-derived cell-free DNA (dd-cfDNA) is an emerging non-invasive biomarker for allograft injury detection. This study aimed to evaluate a new, decentralized dd-cfDNA testing kit against a centralized dd-cfDNA testing service broadly utilized in the United States. Kidney transplant recipients with decentralized and centralized dd-cfDNA measurements and concomitant kidney allograft biopsies were included in the study. 580 kidney allograft recipients from 3 referral centers were included for 603 total evaluations. Correlation between assays was evaluated using r-squared ( r 2 ) and Spearman’s rank correlation test, and associations with rejection using logistic regression analyses and discrimination using area under the curve. Mean dd-cfDNA levels from decentralized and centralized tests were 0.51% ± 0.81% and 0.43% ± 0.78%, respectively. The assays were highly correlated, with r 2 = 0.95 and Spearman’s rank correlation 0.88 ( p < 0.0001). Both tests showed significant association with allograft rejection ( p < 0.0001) and good and similar discriminations to predict rejection (AUC: 0.758 for the decentralized and AUC: 0.760 for the centralized dd-cfDNA; p = 0.8466). Consistency between the assays was also confirmed across clinical scenarios including post-transplant timepoint, allograft stability, and allograft rejection subcategories. This decentralized dd-cfDNA assessment demonstrates high accuracy and value to non-invasively monitor kidney recipients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Paris Cité, Institut national de la santé et de la recherche médicale (INSERM) U970, Paris Institute for Transplantation and Organ Regeneration PITOR, Paris, France.
- Department of Kidney Transplantation, Necker Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
- CareDx, Brisbane, CA, United States.
- Department of Nephrology and Kidney Transplantation, Vall d'Hebron University Hospital, Vall d' Hebrón Research Institute, Vall d' Hebrón Barcelona Campus Hospital, Barcelona Autonomous University, Barcelona, Spain.
- Kidney Transplant Department, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
Zitieren
APA
Loupy, A., Certain, A., Tangprasertchai, N. S., Racapé, M., Ursule-Dufait, C., Benbadi, K., Raynaud, M., Vaskova, E., Marchis, C., Casas, S., Hague, T., Bestard, O., Kervella, D., Lefaucheur, C., Viard, T., & Aubert, O. (2024). Evaluation of a Decentralized Donor-Derived Cell-Free DNA Assay for Kidney Allograft Rejection Monitoring. Transplant International. https://doi.org/10.3389/ti.2024.13919
Vancouver
Loupy A, Certain A, Tangprasertchai NS, Racapé M, Ursule-Dufait C, Benbadi K, et al. Evaluation of a Decentralized Donor-Derived Cell-Free DNA Assay for Kidney Allograft Rejection Monitoring. Transplant International. 2024. doi:10.3389/ti.2024.13919
BibTeX
@article{Loupy2024,
author = {Loupy, Alexandre and Certain, Anaïs and Tangprasertchai, Narin S and Racapé, Maud and Ursule-Dufait, Cindy and Benbadi, Kawthar and Raynaud, Marc and Vaskova, Evgeniya and Marchis, Corina and Casas, Sílvia and Hague, Tim and Bestard, Oriol and Kervella, Delphine and Lefaucheur, Carmen and Viard, Thierry and Aubert, Olivier},
title = {Evaluation of a Decentralized Donor-Derived Cell-Free DNA Assay for Kidney Allograft Rejection Monitoring},
journal = {Transplant International},
year = {2024},
doi = {10.3389/ti.2024.13919}
}
EUVIMED